| Pharmaceutical active ingredients: |
| Fursultiamine |
| Available forms, composition and doses of Alinamin: |
| Tablets; Oral; Fursultiamine 5 mg |
| Alinamin medical category: |
| Human:Vitamin B1 deficiency treating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A11DA01 - Thiamine (Vitamin B1) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Takeda Pharmaceutical |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Alin Nasal | Dexamethasone Sodium Phosphate; Neomycin Sulfate; Phenylephrine Hydrochloride | Chinoin |
| Alin Oftalmico | Dexamethasone Sodium Phosphate; Neomycin Sulfate | Chinoin |
| Alin Tabletas | Dexamethasone | Chinoin |
| Alinal | Phenobarbital; Pipenzolate Bromide | Gulf Pharmaceutical Industries, Julphar |
| Alinam | Chlormezanone | Therabel Pharma |
| Alinamin B12 | Fursultiamine Hydrochloride; Vitamin B12 | Luen Wah Medical; Takeda Pharmaceutical; Zuellig Pharma |
| Alinamin-F Injections | Fursultiamine Hydrochloride | Takeda Pharmaceutical |
| Alinamin-F Odorless | Fursultiamine Hydrochloride; Vitamin B2 (Riboflavin) | Takeda Pharmaceutical; Luen Wah Medical; Zuellig Pharma |
| Alinamin-F Tablets | Fursultiamine Hydrochloride; Vitamin B2 (Riboflavin) | Takeda Pharmaceutical |
| Alinda | Dextrose Monohydrate; Fructose; Phosphoric Acid Dilute | Sanofi-Aventis |